Huff, Charlotte
November 2004
H&HN: Hospitals & Health Networks;Nov2004, Vol. 78 Issue 11, p62
Trade Publication
Discusses the effects of the changes in Medicare coverage for the chemotherapy treatments of U.S. cancer patients in 2005. Percentage of cancer patients who receive the treatment in private clinics; Possibility that the patients would be referred to local hospitals; Criticism of the changes in the drug cost rates reimbursed to doctors by Medicare; Preparations taken by the hospitals regarding the potential increase in the number of inpatients seeking chemotherapy.


Related Articles

  • No effect of supplemental coverage on spending in cancer patients.  // PharmacoEconomics & Outcomes News;Feb2014, Issue 695, p7 

    The article discusses the findings of a study published in "Value in Health" which showed that cancer patients receiving U.S. Medicare assistance are less inclined to avail of supplemental insurance compared to patients without cancer.

  • Cost of Care for Elderly Cancer Patients in the United States. Yabroff, K. Robin; Lamont, Elizabeth B.; Mariotto, Angela; Warren, Joan L.; Topor, Marie; Meekins, Angela; Brown, Martin L. // JNCI: Journal of the National Cancer Institute;5/7/2008, Vol. 100 Issue 9, p630 

    Background Timely estimates of the costs of care for cancer patients are an important element in the formulation of national cancer programs and policies. We estimated net costs of care for elderly cancer patients in the United States for the 18 most prevalent cancers and for all other tumor...

  • Medicare e-prescribing standards set.  // Drug Topics;11/21/2005, Vol. 149 Issue 22, p10 

    This article reports that the U.S. Department of Health and Human Services has approved a final rule to adopt foundation standards for electronic prescribing under Medicare Part D. The standards cover transactions between prescribers and dispensers on new prescriptions and refill requests and...

  • E-Prescribing: Why the Fuss? Adler, Kenneth G. // Family Practice Management;Jan/Feb2009, Vol. 16 Issue 1, p22 

    The article discusses the benefits of electronic prescribing to Medicare in the U.S. Providers who e-prescribe using a "qualified e-prescribing system" are eligible for an incentive payment equal to 2 percent of their Medicare allowed charges as of January 1, 2009. Policymakers support the...

  • Medicare and Drug Pricing. Iglehart, John K. // New England Journal of Medicine;4/17/2003, Vol. 348 Issue 16, p1590 

    Discusses Medicare overpayments to physicians for drugs such as chemotherapeutic agents which are administered to patients in the outpatient setting. Argument of oncologists that they are underpaid for their professional services and practice expenses, so it should not be an issue that they...

  • Unexpected "Donut Hole" Raises Concerns That Patients Will Fail to Fill Needed Prescriptions. Howard-Ruben, Josie // ONS News;Dec2006, Vol. 21 Issue 12, p10 

    This article discusses the implications of donut hole for cancer patients participating in Medicare Part D in the United States. The donut hole represents a gap in coverage for drug expenditures which was predicted to affect a number of patients participating in Medicare Part D. The year of 2006...

  • Pharmacies seek greater role in MTM. Lipowski, Earlene // Drug Topics;3/5/2007, Vol. 151 Issue 5, p26 

    The article reports that pharmacists are seeking greater role in medication therapy management (MTM) services under Medicare Part D plans in the U.S. MTM services are aimed to promote patient understanding about medication use, increase adherence to drug regimens and detect drug-related...

  • Controversial coverage for new wonder drug. Leonard, Bill // HR Magazine;Jul98, Vol. 43 Issue 8, p21 

    Focuses on the issues related to the health insurance coverage of persons taking the anti-impotence drug, Viagra, in the United States. Standards proposed by various states to determine coverage of the drug; Plans of insurers in covering cost of Viagra prescriptions.

  • Warning: Viagra may cause headaches for health insurers. Overman, Stephenie // HR Magazine;Sep98, Vol. 43 Issue 10, p104 

    Focuses on the gender equity, costs and legal concerns for health insurers in the United States brought about by the male impotence drug Viagra. Coverage policies by insurers such as Kaiser Permanente and Aetna U.S. Healthcare; Costs and recommended dosage of the drug; Debate over the...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics